Southeast Asset Advisors’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
Southeast Asset Advisors's ABBV Position: Q3 2026 in Review
Southeast Asset Advisors held its AbbVie (ABBV) position steady in Q3 2026 at 21,450 shares worth $5.61M. The position accounts for 0.57% of the portfolio, ranked #25.
Southeast Asset Advisors first reported a position in ABBV in Q4 2020 and has held it in 24 quarters since. The position peaked at $5.86M in Q3 2025. 4,267 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.
- Southeast Asset Advisors held 21,450 shares of AbbVie worth $5.61M as of Q3 2026.
- Southeast Asset Advisors left its AbbVie share count unchanged in Q3 2026.
- AbbVie made up 0.57% of Southeast Asset Advisors's portfolio in Q3 2026, its #25 holding.
- Southeast Asset Advisors first reported a position in AbbVie in Q4 2020 and has held it in 24 quarters since.
- Southeast Asset Advisors's AbbVie position peaked at $5.86M in Q3 2025.
- 4,267 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.
Based on Southeast Asset Advisors's 13F filing for Q3 2026, filed 13 Nov 2026.